Clinical trial
Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir…
NCT00179335 · Albert Einstein College of Medicine, Other · Completed
Key facts
| NCT number | NCT00179335 |
|---|---|
| Title | Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults |
| Official title | Cross Sectional Case-Sectional Control Pharmacokinetic Study of Efavirenz or Lopinavir/Ritonavir as Part of an Antiretroviral Regimen With Two Nucleosides in HIV-Infected Adults 55 Years of Age or Older Compared With Adults Aged 18-35 Years |
| Lead sponsor | Albert Einstein College of Medicine, Other |
| Collaborators | Abbott Industry University of Alabama at Birmingham |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections |
| Intervention type | Procedure |
| Interventions | Blood drawing to determine drug levels |
| Enrollment | 45 |
| Start date | Aug 1, 2003 |
| Primary completion | Jan 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 26, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: